INTRODUCTION
Reduced beta adrenergic responses have been demonstrated in lymphocytes, granulocytes, and the cardiovascular system of patients with cystic fibrosis (CF)' (1) (2) (3) (4) (5) . In leukocytes, the defect appears to be present in attenuated form in obligate heterozygotes for CF, suggesting that it is inherited and not acquired as a result of disease (1, 4) . This suggestion is further supported by the lack of relation of the CF beta adrenergic abnormality to major organ involvement or to severity of pulmonary disease (1) (2) (3) (4) . The biochemical basis for this abnormality is uncertain. The same cells that fail to produce normal amounts of adenosine 3':5' cyclic monophosphate (cAMP) in response to beta adrenergic agonists respond normally to prostaglandin El (PGEI) (1, 2, 4, 5) , suggesting that the capacity of adenylate cyclase to respond to hormonal stimuli is intact. In fact, adenylate cyclase activity in lymphocyte and granulocyte particulates is normal in its basal state and in response to 5'-guanylyl imidodiphosphate (GppNHp), PGEI, and fluoride, but deficient in response to isoproterenol (2) . This places the abnormality at the level of the beta adrenergic receptor or the receptor-cyclase coupling. Galant et al. (4) reported that in whole granulocytes from patients with CF the number of beta adrenergic receptors is reduced. However, the parents of CF patients, who also had reduced cAMP response to isoproterenol, had normal beta receptor number. Because lymphocytes and granulocytes may differ with respect to beta adrenergic re-ceptor responses to pharmacologic agents (6, 7) and disease (8) , we examined the beta adrenergic receptor in lymphocytes as well as granulocytes from patients with CF.
METHODS
Subjects. Patients were diagnosed as having CF based on sweat chloride >70 meq/liter and the presence of either chronic pulmonary disease of appropriate character, or pancreatic insufficiency, or both. All were 13 to 27 yr of age, had clinical score (9) >69, no acute illness, and had not received treatment with beta adrenergic agents or theophyllines during the previous month. They had been treated with pancreatic enzymes, vitamins, oral or inhaled antibiotics, and, in one case, cimetidine. Obligate heterozygotes for CF were parents of a child meeting the above criteria for diagnosis of CF, denied medical illness or medication usage, and were age 27-45 yr. Healthy controls aged [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] yr were recruited by advertisement and admitted no medication usage and no medical illnesses. The study was approved by the Institutional Review Board, and all subjects granted their informed consent.
Cell preparation. Whole blood was mixed with acid citrate dextrose anticoagulant (1.5 ml/10 ml blood) and centrifuged for 20 min at 180 g. The layer of platelet-rich plasma was removed, and the lower layer restored to its original volume with normal saline. Dextran was added to final concentration 0.8% and the mixture allowed to sediment at room temperature for 30-60 min. The leukocyte-rich saline was layered onto a cushion of Histopaque (Sigma Chemical Co., St. Louis, MO) and centrifuged for 30 min at room temperature at 400 g as described by Boyum (10 CF and normal subjects; F = 9.9, P = 0.003 for CF heterozygote and normal subjects; F = 16.5, P < 0.001 for CF and CF heterozygote subjects; F = 19.9, P < 0.001 for all three genotypes).
responses, and, when the curve was analyzed by Anova, was significantly different from both (P < 0.003). The concentration of isoproterenol required to elicit a half-maximal increase in cAMP concentration (EC50 for isoproterenol) was calculated for each subject, and averaged 2.64±1.7 X 10-7 M for the normal lymphocytes and 8.38±1.5 X 10-7 M for CF lymphocytes (P < 0.01). The value for heterozygotes was intermediate, 6 .43±3.1 X 10-7 M. Addition of propranolol (2 X 10-5 M) to samples containing isoproterenol (10' M) resulted in 85±5% inhibition of cAMP accumulation in all samples. The cAMP response to PGE1 does not differ significantly among CF patients, obligate heterozygotes for CF, and normal controls (Fig. 2) .
Intact granulocyte studies. Basal levels of cAMP were: 2.1±0.6 pmol/106 normal cells, 1.5±0.5 pmol/ 106 CF heterozygote cells, and 1.9±0.7 pmol/106 CF cells. Granulocyte cAMP response to isoproterenol does not vary with age over the range of ages of the present subjects (1) . The cAMP response to isoproterenol in granulocytes from CF patients differs significantly from that of cells from healthy controls (P = 0.03 by Anova), but not from that of obligate heterozygotes for CF (Fig. 3) . The response of granulocytes from obligate heterozygotes for CF to isoproterenol differs significantly from that of control subjects (P = 0.05 by Anova). The concentration of isoproterenol required to elicit a half-maximal increase in cAMP concentration (ECN for isoproterenol) was calculated for each subject, and averaged 1 Fig. 6 ). -log [PGEI] FIGURE4 Stimulation by PGE1 of cAMP levels in intact granulocytes. Subjects are described in the legend to Fig. 2 and symbols, in the legend to Fig. 1 . CF and CF heterozygote subjects do not differ from the controls.
The receptor number was expressed as the number of receptors recovered in the particulate fraction per cell used to prepare that fraction. For two healthy normal subjects, the number of receptors was determined on three occasions at least 1 wk apart. The coefficients of variation were 10 and 19%, comparable to other figures in the literature for intrasubject variability of lymphocyte beta adrenergic receptor number in healthy outpatients eating ad lib. (19) . One study Scatchard plots gave straight lines in each case (r > 0.80, P < 0.05) (Fig. 7) . Again, the data were recalculated using only points obtained at concentrations of ligand < 3 nM. No change in either KD or Bma. resulted in most subjects. In three subjects, KD and Bmax both were reduced by recalculation, but substitution of these new values did not affect the group comparison of CF and normal subjects.
Receptor number was expressed as the number of receptors recovered in the particulate fraction per cell [3H] -DHA(nM) Fig. 8 ).
Ki for (-)-isoproterenol increases in the presence of GppNHp (10-4 M) in both normal and CF granulocyte particulates (Fig. 8, Table II ), but the magnitude of the increase cannot be emphasized, because the preparation studied was not shown to be free of guanine nucleotides.
The number of receptors per cell was not significantly correlated with the percent increase in cAMP in response to isoproterenol or with the EC50 for isoproterenol for intact granulocytes.
DISCUSSION
Patients with CF and their parents have reduced lymphocyte and granulocyte cAMP responses to beta adrenergic stimulation (Figs. 1 and 3) . The patients studied here were relatively well (score >69), had no acute illness, and had taken no beta adrenergic agonists or theophyllines for at least 30 d. We have shown previously that patients with CF with and without pancreatic insufficiency have comparable degrees of beta adrenergic resistance in lymphocytes, granulocytes, and the cardiovascular system, so that it is unlikely that nutritional factors influenced our results (2, 3) . Because there is no correlation between disease severity and the deficient leukocyte cAMP response to beta agents or cardiovascular beta adrenergic responses in vivo (1, 3, 4) , and because age-matched patients with bronchiectasis of non-CF etiology did not display the lymphocyte beta adrenergic abnormality (2) , pulmonary disease per se probably does not produce this abnormality.
Even mildly affected patients with CF might be under some stress and therefore have circulating catecholamine excess and downregulated beta adrenergic receptors. However, adolescent and adult CF patients 00Or with clinical score > 70, a group comparable to those who participated in the present study, had plasma norepinephrine concentrations that were normal in the resting state and in response to physiologic stimuli (standing and isometric exercise) (20) . Therefore, the plasma catecholamine history of the CF patients studied here is likely to be comparable to that of the ambulatory healthy controls. Therefore, the beta adrenergic abnormality in CF probably cannot be attributed to endogenous circulating catecholamine excess leading to adrenergic downregulation.
Because the beta adrenergic defect in CF is observed in lymphocytes, granulocytes, and the cardiovascular system (1) (2) (3) (4) (5) , it is unlikely to be an artifact of distribution of lymphocyte subpopulations, or of the presence of immature circulating granulocytes in CF patients.
In summary, patients with CF have a beta adrenergic defect, which does not appear to be an artifact of cell preparations or the result of pulmonary or pancreatic disease or medication usage. (4) were done on whole granulocytes. Breaking up the cells might alter the configuration of the receptors. However, the CF beta adrenergic defect persists in broken-cell preparations of both lymphocytes and granulocytes and adenylate cyclase response to isoproterenol in particulates correlates well with wholecell cAMP response to isoproterenol (2) . Therefore, this explanation seems unlikely. On the other hand, the intact granulocyte might be subject to artifacts such as uptake of the amine ligand into lysosomes down a pH gradient, as suggested by recent work by Styrt et al. (21) , but this would not explain the reported stereospecificity of the system used by Galant et al. (4, 22) . A more likely explanation for the difference between our results and Galant's is that the patient populations under study are different. We studied only patients with clinical score > 69, whereas Galant et al. (4) included patients with more severe pulmonary disease, with scores as low as 35.
Although Galant et al. (4) found reduced beta adrenergic receptor density in cells from CF homozygotes, they found that obligate heterozygotes for CF, who had reduced cAMP response to isoproterenol in granulocytes, had normal receptor density. In our study, in relatively well patients with CF, beta adrenergic receptor density is normal. Taken together, these findings are consistent with the hypothesis that the heritable aspect of the CF beta adrenergic defect is in the receptor-cyclase coupling, not receptor number. The moderately to severely ill patients with CF included in Abnormal receptor-cyclase coupling may be accompanied by derangement of agonist but not antagonist binding to the beta adrenergic receptor (25) . However, this was not the case in the present study (Tables I and  II) . This may reflect insensitivity of our assay system to such changes or a possible effect of guanine nucleotides retained in the particulate preparations. Alternatively, it may indicate that aniother membrane component required for coupling is defective in CF. Additional studies will be required to resolve these questions.
